Pharmaceutical tablet
Latest Celgene Corporation Patents:
- Preparation of maytansinol
- Cereblon binding compounds, compositions thereof, and methods of treatment therewith
- Pharmaceutical compositions comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and methods of using the same
- Solid forms of 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl) amino]propan-2-ol
- METHODS FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS AND THE USE OF BIOMARKERS AS A PREDICTOR OF CLINICAL SENSITIVITY TO THERAPIES
Portions of the tablet are shown in broken lines to indicate that those portions form no part of the claimed design.
Claims
The ornamental design for a pharmaceutical tablet, as shown and described.
D31133 | July 1899 | Lantz |
D301764 | June 20, 1989 | Contractor et al. |
D302051 | July 4, 1989 | Contractor et al. |
5770225 | June 23, 1998 | Parekh et al. |
5824338 | October 20, 1998 | Jacobs et al. |
D403396 | December 29, 1998 | Lundbom et al. |
D408910 | April 27, 1999 | Lundbom et al. |
D425614 | May 23, 2000 | Chen |
D430285 | August 29, 2000 | Chen |
D431076 | September 19, 2000 | Chen |
D434846 | December 5, 2000 | Chen et al. |
6165513 | December 26, 2000 | Dansereau et al. |
D459798 | July 2, 2002 | Desesquelle |
D506544 | June 21, 2005 | Rinker et al. |
D515202 | February 14, 2006 | Chen et al. |
D534646 | January 2, 2007 | Chang et al. |
D535021 | January 9, 2007 | Stawski et al. |
D564086 | March 11, 2008 | Nielsen et al. |
D671636 | November 27, 2012 | Nishino |
D735315 | July 28, 2015 | Bhat |
D741990 | October 27, 2015 | Ramos |
D754841 | April 26, 2016 | Waldman |
D755949 | May 10, 2016 | Ramos |
D771236 | November 8, 2016 | Becker |
D787042 | May 16, 2017 | Parikh et al. |
D787043 | May 16, 2017 | Parikh et al. |
D813372 | March 20, 2018 | Parikh |
- U.S. Appl. No. 29/531,123, filed Jun. 23, 2015, Parikh et al.
- United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/524,022, dated Apr. 6, 2016.
- United States Patent and Trademark Office, Final Office Action issued in U.S. Appl. No. 29/524,022, dated Oct. 18, 2016.
- United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/524,022, dated Jan. 10, 2017.
- United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/525,253, dated Apr. 11, 2016.
- United States Patent and Trademark Office, Final Office Action issued in U.S. Appl. No. 29/525,253, dated Oct. 18, 2016.
- United States Patent and Trademark Office, Notice of Allowance issued in U.S. Appl. No. 29/525,253, dated Jan. 13, 2017.
- United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/531,113, dated Apr. 12, 2016.
- United States Patent and Trademark Office, Final Office Action issued in U.S. Appl. No. 29/531,113, dated Oct. 18, 2016.
- United States Patent and Trademark Office, Notice of Allowance issued in U.S. Appl. No. 29/531,113, dated Jan. 17, 2017.
- United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/531,123, dated Apr. 11, 2016.
- United Stapes Patent and Trademark Office, Final Office Action issued in U.S. Appl. No. 29/531,123, dated Oct. 18, 2016.
Type: Grant
Filed: Feb 13, 2018
Date of Patent: Dec 4, 2018
Assignee: Celgene Corporation (Summit, NJ)
Inventors: Darshan Parikh (Bridgewater, NJ), Scott Burnside (Wilmington, NC), Sreenivas S. Bhat (Kendall Park, NJ), Jiping Liu (Basking Ridge, NJ)
Primary Examiner: Charles D Hanson
Application Number: 29/637,070